No matter how cynical the overall market is, Vir Biotechnology Inc (VIR) performance over the last week is recorded -9.15%

On Tuesday, Vir Biotechnology Inc (NASDAQ: VIR) was -2.78% drop from the session before settling in for the closing price of $7.56. A 52-week range for VIR has been $6.56 – $13.09.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Healthcare Sector giant saw their annual sales surged by 421.39% over the last five years. When this article was written, the company’s average yearly earnings per share was at 14.45%. With a float of $87.70 million, this company’s outstanding shares have now reached $136.71 million.

The firm has a total of 587 workers. Let’s measure their productivity. In terms of profitability, gross margin is 81.92%, operating margin of -658.31%, and the pretax margin is -685.83%.

Vir Biotechnology Inc (VIR) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Vir Biotechnology Inc stocks. The insider ownership of Vir Biotechnology Inc is 36.32%, while institutional ownership is 49.35%. The most recent insider transaction that took place on Dec 02 ’24, was worth 625. In this transaction EVP and General Counsel of this company sold 76 shares at a rate of $8.22, taking the stock ownership to the 56,973 shares. Before that another transaction happened on Dec 02 ’24, when Company’s Officer proposed sale 76 for $8.22, making the entire transaction worth $625.

Vir Biotechnology Inc (VIR) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 14.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.00% during the next five years compared to -34.12% drop over the previous five years of trading.

Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators

You can see what Vir Biotechnology Inc (VIR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.94. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.88.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.92, a number that is poised to hit -0.87 in the next quarter and is forecasted to reach -3.81 in one year’s time.

Technical Analysis of Vir Biotechnology Inc (VIR)

Analysing the last 5-days average volume posted by the [Vir Biotechnology Inc, VIR], we can find that recorded value of 1.18 million was better than the volume posted last year of 1.07 million. As of the previous 9 days, the stock’s Stochastic %D was 9.07%. Additionally, its Average True Range was 0.55.

During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 18.44%, which indicates a significant increase from 3.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 86.95% in the past 14 days, which was higher than the 65.77% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $8.02, while its 200-day Moving Average is $8.94. Now, the first resistance to watch is $7.53. This is followed by the second major resistance level at $7.70. The third major resistance level sits at $7.84. If the price goes on to break the first support level at $7.21, it is likely to go to the next support level at $7.07. Now, if the price goes above the second support level, the third support stands at $6.90.

Vir Biotechnology Inc (NASDAQ: VIR) Key Stats

There are 137,720K outstanding shares of the company, which has a market capitalization of 1.01 billion. As of now, sales total 86,180 K while income totals -615,060 K. Its latest quarter income was 2,380 K while its last quarter net income were -213,720 K.